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oxifene (5p.g/kg/min) was infused into LAD through the bypass tube for 20 minutes in either 
ischemic or nonischemic situations. 
Results: In the nonischemie heart, raloxifene had no significant hemodynamic and meta- 
bolic effects. However, in the ischemic heart, both coronary blood flow (33±2 to 44±3 ml/ 
100g/rain, p<O.01) and fractional shortening (7.9±0.4 to 11.7±0.7 %, p<0.01) were 
increased by the raloxifene infusion. Lactate extraction ratio (-48.0-~-4.5 to -16.1±4.8 %, 
p<0.01 ) and pH of coronary venous blood (7.271 ±0.010 to 7.340±0.025, p<0.05) were also 
increased by raloxifene, indicating the improvement of myocardial anaerobic metabolism. 
These effects were partially attenuated by pretreatment with either NG-nitro-L-arginine 
methyl ester (L-NAME, the inhibitor of NO synthase) or wortmannin (the inhibitor of phos- 
phatidylinositol 3-kinase (PI3-K)), and completely abolished by ICI182780 (the estrogen 
receptor antagonist) or L-NAME plus charybdotoxin (the blocker of Ca2+-activated K* (Kca) 
channels). Moreover, increases in both Akt activity and the levels of end products of NO 
between coronary venous and arterial blood due to raloxifene was completely attenuated 
by the pretreatment with wortmannin. 
Conclusion: These results suggest that both NO and the opening of KCa channels through 
the activation of estrogen receptors are mainly involved in the mechanism of improving 
myocardial ischemia, and that NO production is mediated by PI3-KJAkt pathway. 
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1122A-163 Higher Procedure Use in the United States Versus 
Canada Among Non-ST Elevation Acute Coronary 
Syndrome Patients Not Associated With Better Quality 
of Life Outcomes 
Padma Kaul, Yuling Fu, David Knight, Nancy Clapp-Channiog, Waoda Sutherland, 
Christopher Granger, Paul W. Armstrong, Daniel Mark, Duke Clinical Research Institute, 
Durham, North Carolina, University of Alberta, Edmonton, Alberta, Canada. 
Comparison of United States (US) and Canadian (CN) practice patterns and outcomes 
offers a natural experiment to examine the relative benefits of aggressive versus conser- 
vative management of non-ST elevation (elev) acute coronary syndrome (ACS) patients 
(pts) and their differential impact on qualify of life (QOL). In a prospectively designed sub- 
study of GUSTO-lib, we examined QOL at baseline and at one-year among a random 
sample of 1222 US and 463 CN pts. There was no change in pts' functional status during 
the 1-year follow-up in either country (Table). By 1-year, CN CABG rates were at per with 
those in the US. However, CN cardiac catheterization and PCI rates continued to be sig- 
nificantly lower. 
In conclusion: contrary to prior findings in the ST-elev MI population, significantly higher 
procedure rates in the US compared to CN did not translate into improved QOL status in 
this non-ST-elev ACS cohort. Our QOL results are aligned with those of earlier clinical tri- 
als showing no association between aggressive intervention and improved clinical end- 
points in this pt population. 
Selected QOL Measures & Procedure Rates at Baseline & 1-Year 
Description Baseline One-Year 
CN US CN US 
Duke Activity Status Index + 20 19 20 19 
Current health perception + 73 75 75 75* 
Vitality + 50 50 54 50 
Mental health + 73 80 87 80* 
PROCEDURES (%) 
Cardiac catheterization 45 83* 56 85* 
PCI 15 34* 24 39* 
CABG 12 19" 24 26 
*Inter-country difference was statistically significant at p<0.05 level 
+Median values 
1122A-164 High-Risk Myocardial Infarction: In-Hospital and One- 
Year Outcome After Primary Angioplasty and 
Thrombolysis: A Prospective Nationwide Multicenter 
Study 
Giuseppe Steffenino, Diego Ardissino, Samuele Baldasseroni, Francesco Chiaralla, 
Donate Lucci, Patrizia Maras, Maurizio Marini, Franceseo Maud, Giovanni Maria 
Santoro, Roberto Violini, Aide P. Maaaioni, on behalf of MISTRAL Investigators, ANMCO 
Research Center, Florence,/ta/~ 
Background. Although primary angioplasty (P-PTCA) is supedor to thrombolysis (TT) in 
randomised trials, this is not true of most registries, and prospective studies in high-risk 
(HR) pts are scarce. We observed the applicability and the acute and long-term out- 
comes of either treatment in HR pts with AMI in the community setting. 
Methods and Results. At 17 sites with, and 30 without, P-PTCA facilities, 2227 pts with 
ST elevation AMI 70 y (17.8%), diabetic >70 y (9%), Killip class >1 (23.7%), SBP 100 b/ 
• m (2.7%), >4 leads with ST deviation (81.9%), previous MI (11.4%), contraindication to 
Tr (10.2%). 
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P-PTCA was performed in 721 pts, (median door-to-balloon time 50 rain), TT in 1090 pts, 
and in 416 pts (18.7%). No reperfusion treatment (RT) was given. The incidence of the 
primary in-hospital combined end-point (EP) (death, reinfarction and stroke) was similar 
in pts with TT (9.2%) and P-PTCA (10.7%) (OR 1.19, 95%CI 0.86-1.63), and it was 
higher (22.6%) (OR 3.30, 95%CI 2.36-4.63, p<0.001 ) in pts with noRT. The cumulated 12 
months combined EP (death, reinfarction, and new admission for angina or congestive 
heart failure) was also similar after TT (26.2%) and P-PTCA (24.6%) (OR 0.92, 95%CI 
0.74-1.14, p=0.45), and it was higher (45.4%) (OR 2.35, 95%CI 1.86-2.98, p<0.001) after 
noRT. At multivariate analysis (Cox), age, antedor AMI, killip class <1, heart rate and sys- 
tolic blood pressure on admission were all significantly associated with both primary EPs. 
The lack of difference in the outcome of pts after either RT was confirmed by the adjusted 
analysis. As compared to pts with TT, the subgroup with P-PTCA <60 min from admis- 
sion showed a trend toward a better in-hospital outcome (OR 0.65, 95%CI 0.42-1.02, 
p=0.06) and a significant benefit at 1 year (OR 0.69, 95%CI 0.52-0.93, p=0.01). 
Conclusions: overall, in this prospective survey, the outcome of pts with HR AMI treated 
with P-PTCA and TT was similar, with a significant advantage of P-PTCA when per- 
formed <lh of admission. Improved management is required for pts currently not receiv- 
ing reperfusion treatment, whose outcome remains poor. 
1122A-165 Six-Year Mortality and Long-Term Risk Model in Older 
Patients Surviving MI 
JoAnne M. Foodv, Yun Wang, Martha J. Radford, Hadan M. Krumholz, Yale University 
School of Medicine, New Haven, Connecticut, Qualidigm, Middletown, Connecticut. 
Background. Outcomes following myocardial infarction are highly variable and it is often 
difficult to accurately predict prognosis, particularly in the elderly. Despite the utility of 
predictive models in clinical practice, few studies have determined the long.term (6 year) 
prognostic significance of readily available demographic, clinical and functional data in a 
large national sample of Mt survivors. 
Methods. We conducted a retrospective cohort study using data from a sample of older 
patients admitted with AM1 in 1992-1993 and a national sample from the Cooperative 
Cardiovascular Project of patients aged >/= 65 years who survived MI from 1994-1995 to 
describe the distribution of death after MI and to develop a simple risk model that would 
accurately stratify eldedy survivors of myocardial infarction and predict their long-term (6 
year) clinical outcomes. 
Results. One year and six year mortality in this cohort of 9118 older patients was 17% 
and 48% respectively. In the derivation set, the factors with the strongest association with 
mortality at both 1 and 6 years were older age, female sex, LVEF <40% CHF during 
admission, diabetes, dementia, prior history of AMI or COPD, length of stay greater than 
12 days and renal dysfunction ( cr > 2.5). Having a revascularization procedure or car- 
diac catheterization during the hospitalization was associated with a decrease in mortal- 
ity. Based on the coefficients in the model, a simple risk score was developed. The C 
statistic for the derivation model was 0.80 and for the validation model is 0.81. 
Conclusions. Mortality rates were high in this older cohort, with the majority of deaths 
occurring in the first 6 months. We demonstrate that a simple risk model was a powerful 
tool to risk stratify older patients over the 6 years following AMI and that predictors of risk 
were remarkably stable over the six years after MI. Knowledge of long-term risk in this 
elderly cohort of MI survivors will aid in clinical decision making with regard to further 
diagnostic testing, interventions and secondary prevention strategies. 
1122A-166 Diabetes-Related Knowledge Is Not Associated With 
Measures of Risk Factor Control in Patients With 
Diabetes and Acute Coronary Syndromes 
Carlos D. Sanchez. Darran K. McGuire. L. Kristin Newby, Vic Hasselblad, Mark N. 
Feinglos, E. Magnus Ohman, Duke Clinical Research Institute, Durham, North Carolina, 
Duke University School of Medicine, Durham, North Carolina. 
Background: Diabetic patients have twice the incidence of acute coronary syndromes 
(ACS) and twice the mortality following ACS compared with non-diabetics. Poor patient 
understanding of diabetes (DM) is thought to impede appropriate self-management, 
accelerating cardiovascular complications. We investigated the relationship between 
patient DM-related knowledge and measures of risk factor control (HbAlc, LDL choles- 
terol (LDLc), and body mass index (BM[)). 
Methods: 200 consecutive patients admitted to a university hospital with DM and ACS 
(ST-segment elevation and non-ST-segment elevation MI or unstable angina) were 
enrolled. At enrollment, clinical .and demographic data were recorded. Each patient com- 
pleted a previously validated DM-ralated knowledge assessment (DRKA). Preliminary 
results for the first 151 patients are included. Complete results, including 6-month clinical 
outcomes (death, MI, and revascularization), will be presented. 
Results: Median age was 61 years; 38% of patients were female; 62% Caucasian, 27% 
African-American, and 11% Lumbee Indian. Mean education level completed was 11th 
grade. Hypertension (86%) and hypedipidemia (65%) were common; 22% of patients 
were current smokers. Duration of DM was >10 years in 50% of patients, and 40% were 
taking insulin. Mean values ± SD were HbAlc 7.9% ± 1.7%; LDLc 105mg/clL ± 36mg/dL; 
BMI 32kg/m2 ± 8 kg/m2. Years of education and DRKA score were moderately corre- 
lated (r=0.501, P<0.0001). HbAlc, LDLc, and BMI showed no correlation with DRKA 
Score (r=0.009; r=-0.034; r=0.178, respectively). The lack of correlation between DRKA 
score and risk factor control measures remained after multivariable adjustment for differ- 
ences in age, race, insulin requirement, duration of DM and years of education. 
Conclusion: Among diabetics admitted with ACS, there is moderate correlation between 
years of education and DM-related knowledge. However, we found no correlation 
between DMoralated knowledge and measures of risk factor control. New strategies must 
be developed that translate understanding of disease into better risk factor modification 
among diabetic patients with ischemic heart disease. 
